Up next

Autoplay

Molecular Testing in Metastatic Gastric/GEJ Cancer

3 Views • 06/30/23
Share
Embed
administrator
administrator
Subscribers
0

David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay